Shared Decision Making for Antipsychotic Medications

Launched by NEW YORK STATE PSYCHIATRIC INSTITUTE · Jun 8, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at how to help young adults, ages 18 to 30, make decisions about their antipsychotic medications. Antipsychotic medications are often used to treat serious mental health conditions like schizophrenia and related disorders. The study will test a tool called the Antipsychotic Medication Decision Aid (APM-DA) to see if it helps people better understand their options and choose the treatment that works best for them. The research aims to understand how shared decision-making works, which means working together with healthcare providers to make informed choices about treatment.

To join the study, participants should have a diagnosis of a psychotic disorder and have experience with antipsychotic medications, whether they are currently taking them or have taken them in the past. Participants will be recruited from specific clinics and will need to be willing to share their thoughts during interviews after medication visits over a period of three months. It’s important to note that those who cannot provide consent or do not speak English may not be eligible for this trial. Overall, this study aims to empower young adults in their treatment decisions and improve their mental health care experience.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Ages 18 to 30 who have experienced nonaffective psychosis with a diagnosis of schizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder, other specified/unspecified schizophrenia spectrum and other psychotic disorders (ICD-10-CM Diagnosis Code F20.x)
• • Current/past experiences with antipsychotic medications (APM; e.g., currently taking any antipsychotic medication, stopped taking, or considering stopping).
• • Receive FEP treatment in one of OnTrackNY clinics/sites randomized to intervention or treatment as usual (TAU) - Willing to participate in research interviews after each APM visit during the study period (3 months)
• Exclusion Criteria:
• • Unable to provide informed consent
• • No experience with APM
• • Not fluent (speaking, reading, writing) in English